In this industry-sponsored webinar, panelists Monica Kraft, MD, FCCP, and Kartik Shenoy, MD, join moderator, Demondes Haynes, MD, FCCP, in a review of AIRSUPRA®, the first and only FDA-approved anti-inflammatory rescue inhaler that treats bronchoconstriction and helps prevent exacerbations.
Originally recorded February 14, 2024
--
Sponsored by AstraZeneca. All opinions expressed and information provided as part of this program are those of the presenters only. The content of this program has not been reviewed by CHEST, and CHEST does not endorse or take any position regarding the contents, opinions, or information associated with this program.
Copyright for this content is held by the American College of Chest Physicians. Permission to redistribute is required.